2011, the year of PrEP. In less than 18 months 6 clinical trials investigating the potential use of HIV antiretrovirals (ARV) for the prevention of HIV acquisition have rocked the HIV prevention world. First it was the South African CAPRISA announcing in July 2010
A survey conducted by SIGMA Research is the first to provide some insights into the prospective attitude of gay and bisexual men towards PrEP in England following the release of the iPrEX study in 2010. Knowledge of PrEP, its acceptability, dosage preference and potential effects
“Put simply. Young people can solve today’s challenges in the AIDS response.” This is with this bold and affirmative statement that UNAIDS started a new collaborative project to develop a global strategy to address the HIV epidemic amongst young people. The project is worthy of
The results of the iPrEX study announced in November 2010 have brought some hope back into the field of HIV prevention. The clinical trial,which investigated the effectiveness of Pre-Exposure Prophylaxis mostly amongst men who have sex with men (MSM), showed that daily dosing of the